Correlation Between Okta and Altamira Therapeutics
Can any of the company-specific risk be diversified away by investing in both Okta and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Okta and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Okta Inc and Altamira Therapeutics, you can compare the effects of market volatilities on Okta and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Okta with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Okta and Altamira Therapeutics.
Diversification Opportunities for Okta and Altamira Therapeutics
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Okta and Altamira is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Okta Inc and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and Okta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Okta Inc are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of Okta i.e., Okta and Altamira Therapeutics go up and down completely randomly.
Pair Corralation between Okta and Altamira Therapeutics
Given the investment horizon of 90 days Okta Inc is expected to generate 0.37 times more return on investment than Altamira Therapeutics. However, Okta Inc is 2.71 times less risky than Altamira Therapeutics. It trades about 0.15 of its potential returns per unit of risk. Altamira Therapeutics is currently generating about -0.16 per unit of risk. If you would invest 7,240 in Okta Inc on August 31, 2024 and sell it today you would earn a total of 402.00 from holding Okta Inc or generate 5.55% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Okta Inc vs. Altamira Therapeutics
Performance |
Timeline |
Okta Inc |
Altamira Therapeutics |
Okta and Altamira Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Okta and Altamira Therapeutics
The main advantage of trading using opposite Okta and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Okta position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.The idea behind Okta Inc and Altamira Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Altamira Therapeutics vs. Pyxis Oncology | Altamira Therapeutics vs. Zura Bio Limited | Altamira Therapeutics vs. Elevation Oncology | Altamira Therapeutics vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Fundamental Analysis View fundamental data based on most recent published financial statements |